1. Home
  2. SHOT vs LSTA Comparison

SHOT vs LSTA Comparison

Compare SHOT & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOT
  • LSTA
  • Stock Information
  • Founded
  • SHOT 2018
  • LSTA 1980
  • Country
  • SHOT United States
  • LSTA United States
  • Employees
  • SHOT N/A
  • LSTA N/A
  • Industry
  • SHOT Biotechnology: Pharmaceutical Preparations
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • SHOT Health Care
  • LSTA Health Care
  • Exchange
  • SHOT Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • SHOT 31.4M
  • LSTA 31.2M
  • IPO Year
  • SHOT 2020
  • LSTA N/A
  • Fundamental
  • Price
  • SHOT $0.53
  • LSTA $2.61
  • Analyst Decision
  • SHOT
  • LSTA Strong Buy
  • Analyst Count
  • SHOT 0
  • LSTA 1
  • Target Price
  • SHOT N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • SHOT 750.8K
  • LSTA 66.3K
  • Earning Date
  • SHOT 03-31-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • SHOT N/A
  • LSTA N/A
  • EPS Growth
  • SHOT N/A
  • LSTA N/A
  • EPS
  • SHOT N/A
  • LSTA N/A
  • Revenue
  • SHOT $652,495.00
  • LSTA N/A
  • Revenue This Year
  • SHOT N/A
  • LSTA N/A
  • Revenue Next Year
  • SHOT N/A
  • LSTA N/A
  • P/E Ratio
  • SHOT N/A
  • LSTA N/A
  • Revenue Growth
  • SHOT 68.01
  • LSTA N/A
  • 52 Week Low
  • SHOT $0.45
  • LSTA $2.19
  • 52 Week High
  • SHOT $4.05
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • SHOT 43.17
  • LSTA 42.17
  • Support Level
  • SHOT $0.45
  • LSTA $2.45
  • Resistance Level
  • SHOT $0.52
  • LSTA $2.74
  • Average True Range (ATR)
  • SHOT 0.05
  • LSTA 0.32
  • MACD
  • SHOT 0.01
  • LSTA -0.05
  • Stochastic Oscillator
  • SHOT 59.06
  • LSTA 16.48

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: